论文部分内容阅读
目的了解2003—2015年北京医院门诊血管紧张素转化酶抑制剂(ACEI)类抗高血压药物使用情况及销售金额,为临床合理用药提供依据。方法对2003—2015年北京医院门诊ACEI类药物用药频度、销售量、销售金额、销售金额占全年销售金额的百分比进行分析。结果 2003—2015年北京医院门诊ACEI类降压药中,贝那普利10 mg销售金额一直较平稳且居第1位,福辛普利、进口雷米普利、培哚普利销售金额较为平稳,依那普利叶酸片自2011年进入北京医院以来,一直处于上升趋势。其他品种药物均处于相对平稳状态。结论北京医院门诊ACEI类抗高血压药物的销售基本稳定,使用合理,符合抗高血压药物的使用原则。
Objective To understand the use and sales of antihypertensive agents of angiotensin converting enzyme inhibitor (ACEI) in Beijing Hospital from 2003 to 2015 and provide the basis for clinical rational drug use. Methods From 2003 to 2015, the frequency, the sales amount, the sales amount, the sales amount and the percentage of the sales amount of the ACEI drugs in Beijing Outpatient Clinic were analyzed. Results Among the ACEI class antihypertensive drugs used in outpatient departments of Beijing Hospital from 2003 to 2015, the sales volume of benazepril 10 mg remained relatively stable and rank first. The sales volume of fosinopril, imported ramipril and perindopril was relatively high Steady, Enalapril folate tablets since entering Beijing Hospital in 2011, has been on the rise. Other varieties of drugs are in a relatively stable state. Conclusions The sales of ACEI antihypertensive drugs in Beijing Hospital are basically stable, and are reasonably used in line with the principle of antihypertensive drugs.